Likewise, elevated expressions of DNMT3A and DNMT3B have been observed in many patient samples, with heightened levels of DNMT3A contributing to the development of hepatocellular carcinoma [42,151]. This evidence concerns the gene DNMT3A and hepatocellular carcinoma.